JP2016522194A5 - - Google Patents

Download PDF

Info

Publication number
JP2016522194A5
JP2016522194A5 JP2016513128A JP2016513128A JP2016522194A5 JP 2016522194 A5 JP2016522194 A5 JP 2016522194A5 JP 2016513128 A JP2016513128 A JP 2016513128A JP 2016513128 A JP2016513128 A JP 2016513128A JP 2016522194 A5 JP2016522194 A5 JP 2016522194A5
Authority
JP
Japan
Prior art keywords
optionally substituted
composition
compound according
subject
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016513128A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016522194A (ja
JP6492060B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/037548 external-priority patent/WO2014183068A2/en
Publication of JP2016522194A publication Critical patent/JP2016522194A/ja
Publication of JP2016522194A5 publication Critical patent/JP2016522194A5/ja
Priority to JP2019038815A priority Critical patent/JP6914287B2/ja
Application granted granted Critical
Publication of JP6492060B2 publication Critical patent/JP6492060B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016513128A 2013-05-10 2014-05-09 肺状態および他の状態の処置 Expired - Fee Related JP6492060B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2019038815A JP6914287B2 (ja) 2013-05-10 2019-03-04 肺状態および他の状態の処置

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361822224P 2013-05-10 2013-05-10
US61/822,224 2013-05-10
PCT/US2014/037548 WO2014183068A2 (en) 2013-05-10 2014-05-09 Treatment of pulmonary and other conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019038815A Division JP6914287B2 (ja) 2013-05-10 2019-03-04 肺状態および他の状態の処置

Publications (3)

Publication Number Publication Date
JP2016522194A JP2016522194A (ja) 2016-07-28
JP2016522194A5 true JP2016522194A5 (enExample) 2017-06-22
JP6492060B2 JP6492060B2 (ja) 2019-03-27

Family

ID=51867886

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016513128A Expired - Fee Related JP6492060B2 (ja) 2013-05-10 2014-05-09 肺状態および他の状態の処置
JP2019038815A Expired - Fee Related JP6914287B2 (ja) 2013-05-10 2019-03-04 肺状態および他の状態の処置

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019038815A Expired - Fee Related JP6914287B2 (ja) 2013-05-10 2019-03-04 肺状態および他の状態の処置

Country Status (8)

Country Link
US (2) US9862690B2 (enExample)
EP (1) EP2994464B1 (enExample)
JP (2) JP6492060B2 (enExample)
CN (2) CN108721295B (enExample)
AU (1) AU2014262471B2 (enExample)
CA (1) CA2912057C (enExample)
IL (1) IL242516B (enExample)
WO (1) WO2014183068A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9862690B2 (en) * 2013-05-10 2018-01-09 University of Pittsburgh—of the Commonwealth System of Higher Education Treatment of pulmonary and other conditions
CN105566241B (zh) * 2016-01-18 2018-05-25 中国药科大学 1-磺酰胺基-4-芳氧基类化合物、制备方法及其医药用途

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4313948A (en) * 1980-11-20 1982-02-02 E. R. Squibb & Sons, Inc. Hypotensive imidazole substituted mercapto-1-oxopropyl-L-prolines
JPS63139339A (ja) * 1986-12-02 1988-06-11 Canon Inc 記録媒体
US5672731A (en) 1994-05-20 1997-09-30 Air Products And Chemicals, Inc. N-vinylformamide/alkyl acrylate Michael adducts
WO1998006720A1 (fr) * 1996-08-09 1998-02-19 Eisai Co., Ltd. Derives de benzopiperidine
US6747055B1 (en) 1998-07-17 2004-06-08 The United States Of America As Represented By The Department Of Health And Human Services Water-soluble drugs and methods for their production
US6333410B1 (en) 2000-08-18 2001-12-25 Immunogen, Inc. Process for the preparation and purification of thiol-containing maytansinoids
US7125870B2 (en) * 2002-11-06 2006-10-24 Bristol-Myers Squibb Company Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme
US7351720B2 (en) 2003-06-12 2008-04-01 Bristol-Myers Squibb Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
KR20060056363A (ko) * 2003-08-06 2006-05-24 각고호우징 게이오기주크 매크로파지 활성화 저해제
US20060276536A1 (en) * 2004-02-12 2006-12-07 Vander Jagt David L Cancer treatment using curcumin derivatives
WO2007098504A1 (en) * 2006-02-24 2007-08-30 Emory University Prodrugs of curcumin analogs
TW200819130A (en) * 2006-07-20 2008-05-01 Otsuka Pharma Co Ltd NF-κB inhibitor
TWI387585B (zh) 2006-09-01 2013-03-01 Dow Agrosciences Llc 殺蟲性之ｎ-取代（雜芳基）烷基烴基硫亞胺
WO2008144011A1 (en) * 2007-05-16 2008-11-27 Avalon Pharmaceuticals Compounds and methods for treating or preventing autoimmune diseases
CN101344958A (zh) 2007-07-09 2009-01-14 上海华燕房屋经纪有限公司 网络独立经纪人系统与方法
ES2563553T3 (es) 2008-04-01 2016-03-15 Novo Nordisk A/S Conjugados de insulina-albúmina
EP2362770A4 (en) * 2008-11-21 2012-05-30 Univ Johns Hopkins COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING RADIATION DAMAGE
CN101475532B (zh) * 2009-02-10 2011-07-20 贵州大学 1,5-二杂环基-1,4-戊二烯-3-酮衍生物及制备方法和用途
US20120046357A1 (en) * 2009-05-01 2012-02-23 Profectus Biosciences, Inc. Benzamide and Napthamide Derivatives Inhibiting Nuclear Factor-Kappa (B) - (NK-kB)
EP2477698A2 (en) * 2009-09-18 2012-07-25 Centre National de la Recherche Scientifique Compounds useful against kinetoplastideae parasites
CN103086958A (zh) * 2011-11-04 2013-05-08 中国科学院上海药物研究所 NFκB通路激活抑制剂、其制备方法、药物组合物及用途
US9862690B2 (en) * 2013-05-10 2018-01-09 University of Pittsburgh—of the Commonwealth System of Higher Education Treatment of pulmonary and other conditions

Similar Documents

Publication Publication Date Title
JP2016534153A5 (enExample)
JP2017505761A5 (enExample)
JP2015517489A5 (enExample)
JP2015057436A5 (enExample)
JP2019507781A5 (enExample)
HU229552B1 (en) Pharmaceutical composition containing mixture of organic compounds for the treatment of air way diseases
AR087521A1 (es) Proteinas y peptidos modificados
JP2016516808A5 (enExample)
WO2009050726A3 (en) Compositions and methods for improved delivery of bupropion
EP4245368A3 (en) Migraine prevention and treatment
JP2016510012A5 (enExample)
JP2016511753A5 (enExample)
WO2014016548A3 (en) Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
JP2016510326A5 (enExample)
CN107708697B (zh) 纤维化病治疗剂
JP2018538273A5 (enExample)
JP2013538857A5 (enExample)
JP2016519106A5 (enExample)
CN103857394A (zh) 四氢甲基嘧啶羧酸的治疗应用
JP2016522194A5 (enExample)
JP2016210814A (ja) カルボン酸フェニルケトン化合物およびその薬学的使用
JP2018514564A5 (enExample)
MX2018014425A (es) Beta-horquilla peptidomimetica con actividad inhibidora de elastasa y formas de dosificacion en aerosol de la misma.
JP2019507182A5 (enExample)
MX2017015192A (es) Derivado de bisamida de acido dicarboxilico como agente que estimula regeneracion de tejidos y recuperacion de funcion tisular disminuida.